To investigate the potential beneficial effect of insulin-like growth factor-1 (IGF-1) in BMSC transplantation therapy of uterus injury and the underlying molecular mechanisms, rat BMSCs were isolated and cultured. The relative expressions of IGF-1 and IL-10 were determined by RT-PCR and immunoblotting. The secretory IL-10 and released E2 were measured using ELISA kits. The relative vWF and a-SMA expressions were determined by immunohistochemistry. The direct binding of NFjB subunit p50 with IL-10 promoter was analysed by chromatin immunoprecipitation assay. The regulation of IL-10 expression by p50 was interrogated by luciferase reporter assay. Our data demonstrated that IGF-1 expression in BMSCs induced IL-10 expression and secretion, which was further enhanced by E2-PLGA. IGF-1 overexpression improved BMSCs transplantation therapy in rat uterus injury. We further demonstrated that both inhibition and knockdown of p50 abolished IGF-1-induced expression and secretion of IL-10 in BMSCs, which consequently compromised the IGF-1 conferred therapeutic benefits against uterus injury. Furthermore, we elucidated that p50 regulated IL-10 expression via direct association with its promoter.
certain curative effect for the mild and moderate cases. 3 However, the prognosis for the severe cases is unsatisfactory and the incidence of recurrent adhesion up to 20%-62.5%, and frequently associates with irreversible impairment with respect to the receptivity and fertility. 4 Therefore, to improve the proliferation and regeneration of endometrial cells, which in turn to reconstruct the endometrial structure and restore the endometrial functioning, is the radical curation for endometrial damage to improve pregnancy rate.
Bone marrow-derived mesenchymal stem cells (BMSCs) are multipotent stem cell with potential to differentiate into array of mature cell types, which are increasingly clinically exploited for regenerative medicines against complicated tissue damages. 5 Our previous study demonstrated promising therapeutic effect of minimally invasive
BMSCs transplantation in the uterine prolapse rat model. 6 Likewise,
another investigation showed that BMSCs differentiated into endometrial epithelial cells, which promoted proliferation of endometrial stromal cells and accretion of endometrium, and eventually contributed to the elevated pregnancy rate in the endometrial damage animal model. 7 More importantly, Singh et al proposed the autologous stem cell transplantation as a novel cell-based therapy for refractory Asherman's syndrome. 8 Mechanistically, the transplanted
BMSCs have the potential to activate the resident uterine endometrial stem cells via autocrine and paracrine pathway and motivate cell interactions to reconstruct the injured uterine endometrium. 9 Moreover, it is convincing that the endometrial stem cells highly likely originate from BMSCs, 10 which fosters the hypothesis of the dual function of BMSCs in endometrial repair via both direct differentiation into endometrial epithelial cell and activation of the resident endometrial stem cell. In this study, we inoculated the autologous BMSCs directly into uterine cavity in the endometrial damage rat model to improve endometrial regeneration and restore endometrial functions. However, with the intrinsic limitation that low proportion of stem cells in bone marrow cell population and declined differentiative potency with age, 10 the therapeutic effect of direct injection of BMSCs is greatly inferior to the control currently, which immediately imposes two critical issues for clinical applications: to improve the BMSCs survival, attachment, proliferation and differentiation; to improve the differentiated epithelial cell proliferation and eventually restoration of endometrium.
Insulin-like growth factor-1 (IGF-1) exists in both endometrial epithelial cells and basal cells with critical physiological functions. In response to the oestrogen stimulations, IGF-1 binds to its receptor on the epithelial and basal cell surfaces to significantly promote cell proliferation. 11 Moreover, IGF-1 suppresses inflammatory reaction and fibrous scar formation via inhibition of inflammatory cytokine release. 12 IGF-1 also plays an important role in angiogenesis via upregulation of vascular endothelial growth factor (VEGF). 13 Notably, IGF-1 also promotes BMSCs proliferation and differentiation into endometrial epithelial cell and stimulates BMSCs migration to damage sites and involves in tissue repair. 14 Therefore, elevation of secreted IGF-1 in endometrium might provoke the proliferation and differentiation of BMSCs into endometrial epithelial cell and basal cell, which in turn reinforces the differentiative potential of BMSCs via array of secretory cytokines in a positive feedback loop, and this synergistic effect consequently contributes to endometrial repair and regeneration. In line with this notion, here we established IGF-1-overexpressing BMSCs to explore its beneficial effect in treatment of endometrial damage.
Accumulative investigations suggest that oestrogen is indispensable for endometrial regeneration and repair, and the steady and persistent intrauterine oestrogen supply is critical for this processing. 15 We have previously prepared the sustained release nanoparticles with biodegradable poly(lactide-co glycolide-co-caprolactone, PLGA), which remarkably alleviated pelvic floor dysfunction both in vitro and in vivo with excellent biostability and biocompatibility. 16 Therefore, we will continuously adopt this strategy in this study to sustain consistent supply of oestrogen to stimulate endometrial regeneration.
| MATERIALS AND METHODS

| Primary rat BMSC isolation and culture
The animal study was performed in strict accordance with the guideline of the Animal Care and Use Committee in the Xinhua Affiliated
Hospital of Shanghai Jiao Tong University. Rat BMSCs were isolated and cultured as previously described. 9 In brief, the 2-month-old female rats were killed by overdosing ketamine. The femora and tibias were isolated and thoroughly rinsed with phosphate-buffered saline (PBS, Gibco, Grand Island, NY, USA). The muscle and extraoral tissues were cautiously removed, and the marrow cells in the bone cavities were completely flushed out with low-glucose Dulbecco's modified Eagle's medium (DMEM, Gibco, USA). The resultant lavage was passed through 100-lm cell strainer (BD Bioscience, Franklin
Lakes, NJ, USA) and centrifuged to collect single cells, which were then resuspended in LG-DMEM supplemented with 12.5% foetal bovine serum (BSA, Gibco, USA), 19 insulin-transferrin-selenium (ITS, Gibco, USA), 10 ng/mL basic fibroblast growth factor (bFGF, Gibco, USA) and 1% penicillin-streptomycin-glutamine (PSG from Gibco, USA). The isolated cells were seeded into 100-mm Petri dish and maintained at 37°C in a humidified incubator supplied with 5%
CO2. The fresh medium was replaced every 2 days, and the logphase cells of passage 3-5 were used for the following experiments.
Transfection was performed with lipofectamine 2000 unless indicated and in accordance with the manufacturer's instruction. 2.4 | E2-loaded poly(lactide-coglycolide-co-
caprolactone) nanoparticles
The PLGA-NPs were prepared as described previously, 6 and double- The relative expression of target gene was calculated by the 2 ÀΔΔCt method and normalized to GAPDH. RT-PCR results were also verified by agarose gel electrophoresis, with images shown below respective panels.
| Western blot
The 
| ELISA
The secretory IFG-1 was determined using the commercial Rat IGF-1
Quantikine ELISA Kit (MG100, R&D SYSTEMS, USA) in accordance with the manufacturer's instruction. Briefly, the conditioned medium was collected from indicated cell culture and subjected to centrifugation to remove any cell debris. 50 lL of supernatant was mixed with 50 lL of assay diluent into each well of 96-well plate and incubated at room temperature for 2 hours on a horizontal orbital microplate shaker. The supernatant was aspirated completely, and wells were 
| Rat uterine horn damage model and BMSC transplantation
The vaginal smears were collected daily in the early morning. In total, 32 female Sprague-Dawley rats with average body weight 250-300 g and four consecutive 4-day oestrus cycles were randomly and equally divided into four groups: sham-operated group, spontaneous repair group, collagen/BMSCs group, collagen/BMSCs-IGF-1. To establish uterine horn damage model, the rats were first anaesthetized and the uterine horns were exposed via a low abdominal midline incision. A segment (1.5 9 0.5 cm) was resected from the horn of the uterine with the side of mesometrium left intact. The collagen scaffolds with or without BMSCs were sutured to replace the excised segments. For spontaneous repair, the uterine horns with complete haemostasis and obvious defects were left open to allow healing without further treatments. For sham operation, the uterine horns were left intact after exposure by an abdominal midline incision. The procedure was illustrated in Figure S1 . All rats were intramuscularly administrated with penicillin twice a day for three consecutive days after surgery to prevent systematic infection.
| Histological examination
The regenerative region of uterine horn was resected and fixed with 4% paraformaldehyde overnight, dehydrated with graded alcohol and embedded in paraffin. The tissues were sliced into 5 lm sections transversally with microtome (Leica RM2255, German). Tissue sections were then subjected to immunostaining with anti-a-smooth muscle actin antibody (a-SMA, ab5694, 1:200) and anti-von Willebrand factor antibody (vWF, ab6994, 1: 10000), respectively. The muscle actin density was estimated by the percentage of a-SMApositive area with Image-Pro Plus software, and capillary vessels were counted under light microscope in at least three random fields.
| Statistical analysis
All data in this study were acquired from at least three independent experiments. The results were analysed with SPSS 23.0 and presented as mean AE SD. One-way analysis of variance (ANOVA) was employed for multiple comparisons followed by Turkey post hoc test. The statistical significances were calculated as P values, and P < .05 was considered statistically different.
3 | RESULTS
| IGF-1 expression in BMSCs induces IL-10 expression and secretion
First of all, we confirmed the identity of the rat BMSCs ( Figure 1A) by flow cytometry analysis, showing that these cells were positive for surface markers CD44, CD73 and CD90, while negative for surface marker CD45 ( Figure 1B) , as reported previously. 17 Next, to investigate the potential stimulatory effect of IGF-1 in promotion The previous study suggested that E2 directly associated with ER-a, which in turn induced IGF-1 expression in endometrial epithelium cells and eventually improved injury repair and regeneration. 18 Here, we encapsulated E2 in PLGA nanoparticles (Figure 2A ) to investigate the potential synergistic effect in induction of IGF-1 expression and secretion in BMSCs cells. We first characterized the controlled releasing behaviour of E2-PLGA by directly assaying free E2 in regular culture medium up to 7 days using commercial ELISA kit. As shown in Figure 2B , the released percentage of E2 gradually increased during the experimental time span, and around 80% of E2 was free and available in the culture medium. Next, we compared the stimulatory effects between direct administration of E2 with controlled release from E2-PLGA nanoparticles. The direct dosage of E2 induced acute up-regulation of IGF-1 which peaked at day 4 and gradually returned to its original level. However, the IGF-1 expression in E2-PLGA-treated BMSCs cell increased in a sustainable manner and reached the peak level at day 7 ( Figure 2C) . Notably, the maximum induced expression level of IGF-1 in E2-PLGA group was significantly higher than E2 group, which indicated that E2-PLGA was superior to E2 to induce IGF-1 expression with respect to either intensity or sustainability ( Figure 2D ). Therefore, we employed E2-PGLA and intramuscularly administrated every 7 days to maximize the therapeutic effect of transplanted BMSCs to treat injured uterus hereafter.
3.3 | IGF-1 improved BMSCs transplant therapy in rat uterus injury We further consolidated our previous observation, and NF-jB p50 subunit was specifically knocked down by shRNA. The knockdown efficiency was first validated by RT-PCR as shown in Figure 5A and immunoblotting in Figure 5B . The inhibition of p50 did not affect IGF-1 at both transcript and protein levels, which was consistent with the results from p50sr-treated BMSCs ( Figure 5B,C) . In contrast, shRNA-mediated knockdown of p50 almost entirely abolished IGF-1-induced expression and secretion of IL-10 in BMSCs cells (Figure 5D,E) , which unambiguously demonstrated that p50 functioned downstream IGF-1 in up-regulation IL-10.
| NF-jB p50 subunit induces IL-10 expression by directly binding to its promoter region
Our previous results showed the critical role of p50 in induction of IL-10 expression and secretion by IGF-1, which the underlying molecular mechanism was still to be defined. The close inspection of IL-10 promoter sequence has identified a proximal putative F I G U R E 6 NF-jB p50 subunit induces IL-10 expression by directly binding to its promoter region. A, The putative p50 binding site was identified in the promoter region of IL-10. Wild-type (Wt-LUF) and mutated (Mut-LUF) sequences from IL-10 promoter were cloned, respectively, to the 5 0 -prime of luciferase reporter gene (LUF). B, Binding of p50 to the putative binding site in IL-10 promoter was analysed by ChIP assay using control IgG and p50 antibody (Ab), respectively. C, Luciferase activities of Wt-LUF or Mut-LUF constructs described in (A) were measured in BMSCs transfected with control vector or p50, respectively. D and E, Levels of IL-10 mRNA with representative gel images of PCR products shown below the bar graph (D), and in media (E) were examined in BMSCs transfected with control vector or p50, respectively. Values are mean AE SD. **P < .01, *P < .05, vs respective control binding site of p50 as illustrated in Figure 6A . The direct binding of p50 to the predicted sequence was experimentally confirmed by ChIP assay, which showed around sevenfold enrichment of p50-responsive element sequence in p50-immunoprecipitate in comparison with IgG control ( Figure 6B ). Furthermore, we constructed either wild-type or mutated IL-10 promoter-driven luciferase reporter plasmids to intuitively investigate the regulatory effect of p50 on IL-10 (illustrated in Figure 6A ). As shown in Fig 
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